loading

Finanzdaten der Arcturus Therapeutics Holdings Inc-Aktie (ARCT)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
3.68%
28.30
29.38 22.77 41.67 49.86
Operating Expenses
13.61%
39.92
46.21 56.16 52.41 70.98
Benefits Costs and Expenses
13.76%
37.48
43.46 52.77 48.79 67.22
Costs And Expenses
13.76%
37.48
43.46 52.77 48.79 67.22
Depreciation and Amortization
0.12%
0.80
0.801 0.819 0.90 0.90
Operating Income/Loss
30.96%
-11.62
-16.83 -33.39 -10.74 -21.13
Income/Loss From Continuing Operations Before Tax
34.81%
-9.176
-14.08 -30.01 -7.12 -17.37
Income Tax Expense/Benefit
0.004
- -0.004 -0.217 -0.15
Income/Loss From Continuing Operations After Tax
34.78%
-9.18
-14.08 -30.00 -6.903 -17.22
Net Income/Loss
34.78%
-9.18
-14.08 -30.00 -6.903 -17.22
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.08%
27.13
27.11 0.03 27.06 26.97
Diluted Average Shares
0.08%
27.13
27.11 0.03 27.06 26.97
Basic Earnings Per Share
34.62%
-0.34
-0.52 -1.11 -0.26 -0.64
Diluted Earnings Per Share
34.62%
-0.34
-0.52 -1.10 -0.26 -0.64
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
Kapitalisierung:     |  Volumen (24h):